Company
Aktis Oncology
| Industry | clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Aktis Oncology | Series B Funding | 2024-09-30 |